mRNA COVID-19 vaccine: Allergic reactions rare, typically mild and treatable, according to Stanford study

Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine. The findings will be published online Sept. 17 in JAMA Network Open. We wanted to understand the spectrum of allergies to the new vaccines [...]

The post mRNA COVID-19 vaccine: Allergic reactions rare, typically mild and treatable, according to Stanford study appeared first on Outbreak News Today.